Fluidigm: Funding, Investors & Team (Sep 2026)
Fluidigm Corporation develops and distributes systems based on the properties of integrated fluidic circuits to control precisely fluids on a nano volume scale. The company's product line includes the TOPAZ system, which is used for protein crystallization; and the BioMark system, which is used for genetic analysis. Fluidigm Corporation was founded as Mycometrix Corporation in 1999 and was renamed as Fluidigm Corporation in 2001. The company is based in San Francisco, California.
Fluidigm has raised $250M across 1 funding round on record, the most recent a Post-IPO Equity of $250M announced in Jan 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Fluidigm Company Profile and Key Stats
Latest funding round on record: Jan 2022.
Fluidigm Funding Rounds
Fluidigm Founders and Leadership Team
Contact details for the Fluidigm team: 1 of 1 has an email address on file.
Start 14-day free trial →Fluidigm Funding Compared to Other Biotechnology Startups
Fluidigm's latest round of $250M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Fluidigm in Biotechnology and South San Francisco
Companies Similar to Fluidigm
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Fluidigm Funding FAQs
What does Fluidigm do?
Fluidigm Corporation develops and distributes systems based on the properties of integrated fluidic circuits to control precisely fluids on a nano volume scale. The company's product line includes the TOPAZ system, which is used for protein crystallization; and the BioMark system, which is used for genetic analysis. Fluidigm Corporation was founded as Mycometrix Corporation in 1999 and was renamed as Fluidigm Corporation in 2001. The company is based in San Francisco, California.
How much funding has Fluidigm raised?
Fluidigm has raised $250M across 1 round on record. The most recent is a Post-IPO Equity of $250M announced in Jan 2022.
When did Fluidigm last raise funding?
Fluidigm's most recent funding round on record is a Post-IPO Equity of $250M, announced in Jan 2022.
Who is the CEO of Fluidigm?
Christopher Linthwaite is listed as CEO at Fluidigm.
Where is Fluidigm headquartered?
Fluidigm is based in South San Francisco, California, United States.
How many employees does Fluidigm have?
Fluidigm is in the 501-1000 employee band.
How does Fluidigm's funding compare to other Biotechnology startups?
Fluidigm's latest round of $250M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Fluidigm Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Fluidigm is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.